![Khaled Bahi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Khaled Bahi
Director of Finance/CFO at ONWARD MEDICAL N.V.
Profile
Khaled Bahi is currently the Chief Financial Officer at Onward Medical NV.
Previously, he held the position of Chief Financial Officer at Symetis SA from 2014 to 2019.
He also worked as the Chief Financial Officer at Stilla Technologies SA. Mr. Bahi is a graduate of the Swiss Federal Institute of Technology.
Khaled Bahi active positions
Companies | Position | Start |
---|---|---|
ONWARD MEDICAL N.V. | Director of Finance/CFO | 2023-09-30 |
Former positions of Khaled Bahi
Companies | Position | End |
---|---|---|
SYMETIS SA | Director of Finance/CFO | 2019-09-30 |
Stilla Technologies SA
![]() Stilla Technologies SA Miscellaneous Commercial ServicesCommercial Services Stilla Technologies SA operates as a biotechnology company that focuses on the development genetic tests. It provides crystal digital PCR, a next-generation technology for absolute quantification of nucleic acids. The company was founded by Remi Dangla, Etienne Fradet and Clement Gay in 2013 and is headquartered in Villejuif, France. | Director of Finance/CFO | - |
Training of Khaled Bahi
Swiss Federal Institute of Technology | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ONWARD MEDICAL N.V. | Commercial Services |
Private companies | 2 |
---|---|
Symetis SA
![]() Symetis SA BiotechnologyHealth Technology Symetis SA develops minimally invasive heart valve replacement devices. Its products include ACURATE TA and ACURATE neo. The company was founded by Simon P. Hoerstrup and Gregor Zünd on September 5, 2001 and is headquartered in Ecublens, Switzerland. | Health Technology |
Stilla Technologies SA
![]() Stilla Technologies SA Miscellaneous Commercial ServicesCommercial Services Stilla Technologies SA operates as a biotechnology company that focuses on the development genetic tests. It provides crystal digital PCR, a next-generation technology for absolute quantification of nucleic acids. The company was founded by Remi Dangla, Etienne Fradet and Clement Gay in 2013 and is headquartered in Villejuif, France. | Commercial Services |
- Stock Market
- Insiders
- Khaled Bahi